aid: excision
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/excision.png
name: Excision
description: 'Excision BioTherapeutics is a clinical-stage biotechnology company developing CRISPR-based
  in vivo gene-editing therapies aimed at curing serious viral infectious diseases. Its programs apply
  multiplexed CRISPR editing delivered via AAV vectors to excise viral DNA from the host genome, led by
  EBT-101, an investigational one-time therapy for HIV. Excision is a therapeutics company with no public
  developer API, SDK, or documentation surface; this profile is maintained in the API Evangelist network
  as a venture-portfolio company record rather than an API producer.'
url: https://raw.githubusercontent.com/api-evangelist/excision/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- norwest-venture-partners
x-tier: stub
x-tier-reason: therapeutics-company-no-api-surface
x-sector: biotechnology
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-19'
tags:
- Company
- Biotechnology
- CRISPR
- Gene Editing
- Therapeutics
- Life Sciences
- Infectious Disease
- Venture Backed
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/excision-domain-security.yml
- type: Website
  url: https://excision.bio
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence